No profile data available.
Integra LifeSciences Holdings Corporation (IART) is a healthcare company in the targeted healthcare equipment industry, based in Princeton, United States, with about 4,427 full-time employees.
It reported revenue of $1.64 billion for fiscal year 2025, up 1.5% from fiscal year 2024, and net income of -$516.47 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $391.92 million, up 2.4% from a year before. Its largest business segment, Specialty Surgery, brought in 73% of segment revenue in fiscal year 2025; United States was the largest region with 74%. Its market capitalization was $1.05 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Integra LifeSciences Holdings reported $1.64 billion in revenue for fiscal year 2025, up 1.5% from $1.61 billion in fiscal year 2024. In Q1 2026 revenue was $391.92 million.
Specialty Surgery, with $1.20 billion or 73% of segment revenue in fiscal year 2025. Next: Tissue Reconstruction (27%).
United States: 74% of revenue by region in fiscal year 2025, followed by Asia Pacific (12%).
$1.05 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Nanobiotix S.a. (NBTX), Staar Surgical Company (STAA), Procept BioRobotics Corporation (PRCT), Ceribell, Inc. (CBLL).